VMDNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
VIEMED HEALTHCARE, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026
$9.59+0.11 (+1.16%)
Close on Oct 19, 2026
- Market cap
- $394.40M
- P/E (TTM)
- 26.6
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
71.3%
27M of 38M shares
Institutional holders
167
29 new, 11 sold out
Net institutional buying
2M
In Q2 2026
Insider trades, 12 months
0 buys · 9 sales
Net sold $1.59M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Casey Hoyt | 3,116,189 | 8.00% | 13G (passive) amendment | Dec 31, 2023 |
| Kissel Edward Urban | 2,736,472 | 7.20% | 13G (passive) amendment | Sep 30, 2025 |
| Thrivent Financial For Lutherans | 2,705,000 | 6.80% | 13G (passive) amendment | Mar 31, 2025 |
| BlackRock Portfolio Management LLC | 2,540,114 | 6.40% | 13G (passive) | Jun 30, 2025 |
| Michael Moore | 2,294,018 | 5.90% | 13D (active) amendment | Sep 24, 2026 |
| BlackRock, Inc. | 2,278,664 | 5.80% | 13G (passive) amendment | Mar 31, 2025 |
| MacArthur Robert Symmes | 2,186,472 | 5.50% | 13G (passive) | Jun 24, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of VMD | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,788,307 | 12.57% | $54.59M | +165,745 | 0.00% |
| Forager Capital Management, LLC | 2,141,184 | 5.62% | $24.41M | −684,687 | 9.18% |
| Vanguard Capital Management LLC | 1,321,676 | 3.47% | $15.07M | +18,292 | 0.00% |
| Nantahala Capital Management, LLC | 1,264,890 | 3.32% | $14.42M | +381,107 | 0.24% |
| Goldman Sachs Group Inc | 1,222,534 | 3.21% | $13.94M | −199,100 | 0.00% |
| First Eagle Investment Management, LLC | 1,070,314 | 2.81% | $12.20M | +540,657 | 0.01% |
| Ameriprise Financial Inc | 1,006,195 | 2.64% | $11.47M | +107,876 | 0.00% |
| Geode Capital Management, LLC | 973,744 | 2.56% | $11.10M | +194,222 | 0.00% |
| Raffles Associates LP | 807,382 | 2.12% | $9.20M | +393,691 | 4.04% |
| Arrowstreet Capital, Limited Partnership | 786,269 | 2.06% | $8.96M | +75,083 | 0.00% |
| State Street Corp | 762,097 | 2.00% | $8.69M | +19,138 | 0.00% |
| Panagora Asset Management Inc | 538,625 | 1.41% | $6.14M | +66,528 | 0.02% |
| Punch & Associates Investment Management, Inc. | 533,466 | 1.40% | $6.08M | −3,895 | 0.30% |
| Two Sigma Investments, LP | 438,851 | 1.15% | $5.00M | +25,457 | 0.00% |
| Renaissance Technologies LLC | 425,900 | 1.12% | $4.86M | −16,300 | 0.01% |
| Acadian Asset Management LLC | 398,586 | 1.05% | $4.54K | +233,299 | 0.01% |
| Creative Planning | 360,356 | 0.95% | $4.11M | +139,954 | 0.00% |
| Tocqueville Asset Management L.P. | 342,100 | 0.90% | $3.90M | −130,000 | 0.05% |
| Martin & Co Inc /Tn/ | 340,771 | 0.89% | $3.88M | +67,770 | 0.61% |
| Bard Associates Inc | 339,672 | 0.89% | $3.87M | −269 | 0.86% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 167 | 27M | 71.3% | 29 / 72 | 34 / 11 | 4M | 2M |
| Q1 2026 | 150 | 25M | 65.3% | 32 / 54 | 41 / 12 | 5M | 2M |
| Q4 2025 | 132 | 24M | 63.0% | 20 / 44 | 42 / 14 | 2M | 2M |
| Q3 2025 | 131 | 25M | 64.6% | 13 / 44 | 46 / 9 | 3M | 4M |
| Q2 2025 | 127 | 26M | 67.3% | 11 / 61 | 35 / 22 | 3M | 2M |
| Q1 2025 | 139 | 25M | 65.3% | 11 / 53 | 42 / 10 | 2M | 2M |
| Q4 2024 | 141 | 25M | 66.4% | 30 / 45 | 28 / 8 | 2M | 2M |
| Q3 2024 | 121 | 25M | 66.4% | 22 / 40 | 26 / 15 | 6M | 4M |
| Q2 2024 | 116 | 27M | 70.6% | 19 / 54 | 28 / 15 | 4M | 3M |
| Q1 2024 | 112 | 25M | 66.7% | 21 / 36 | 28 / 13 | 4M | 4M |
| Q4 2023 | 104 | 25M | 66.8% | 12 / 33 | 35 / 20 | 4M | 2M |
| Q3 2023 | 112 | 24M | 61.8% | 20 / 38 | 33 / 10 | 2M | 2M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of VMD | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 912,713 | 2.40% | $10.40M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 870,045 | 2.28% | $9.92M | 0.01% | Jun 30, 2026 |
| Columbia Small Cap Value Discovery Fund | 566,630 | 1.49% | $6.61M | 0.26% | Jul 31, 2026 |
| BlackRock Advantage Small Cap Core Fund | 485,288 | 1.27% | $4.78M | 0.09% | May 29, 2026 |
| First Eagle Small Cap Opportunity Fund | 467,300 | 1.23% | $5.45M | 0.19% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 373,459 | 0.98% | $4.26M | 0.00% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 372,227 | 0.98% | $4.34M | 0.01% | Jul 31, 2026 |
| iShares Russell 2000 Growth ETF | 319,961 | 0.84% | $3.65M | 0.02% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 171,949 | 0.45% | $1.69M | 0.01% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 170,736 | 0.45% | $1.68M | 0.00% | May 31, 2026 |
| BlackRock Advantage Small Cap Growth Fund | 124,615 | 0.33% | $1.42M | 0.17% | Jun 30, 2026 |
| iShares Micro-Cap ETF | 114,129 | 0.30% | $1.30M | 0.09% | Jun 30, 2026 |
| First Trust Dow Jones Select MicroCap Index Fund | 110,694 | 0.29% | $1.26M | 0.48% | Jun 30, 2026 |
| Columbia Variable Portfolio - Small Cap Value Discovery Fund | 102,520 | 0.27% | $1.17M | 0.26% | Jun 30, 2026 |
| Fidelity SAI Small-Mid Cap Momentum Index Fund | 101,049 | 0.27% | $1.18M | 0.03% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| William Frazier | Chief Medical Officer, Director | 83,214 | 0.22% | Jun 26, 2026 |
| Casey Hoyt | Chief Executive Officer, Director | 2,349,320 | 6.17% | Feb 2, 2026 |
| William Todd Zehnder | Chief Operating Officer, Director | 401,677 | 1.05% | Feb 2, 2026 |
| Michael Moore | President | 1,774,902 | 4.66% | Mar 20, 2026 |
| Jeremy Trahan | General Counsel | 49,431 | 0.13% | Feb 2, 2026 |
| Jerome Cambre | Vice President of Sales | 106,443 | 0.28% | Feb 2, 2026 |
| Trae Fitzgerald | Chief Financial Officer | 105,638 | 0.28% | Feb 2, 2026 |
| Nitin Kaushal | Director | 161,361 | 0.42% | Aug 19, 2026 |
| Sabrina Heltz | Director | 82,520 | 0.22% | Aug 19, 2026 |
| Randy E. Dobbs | Director | 142,253 | 0.37% | Aug 19, 2026 |
| Timothy Smokoff | Director | 94,304 | 0.25% | Aug 19, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Randy E. Dobbs Director | Aug 19, 2026 | Returned to company | −4,191 | $8.94 | $37.47K | 142,253 |
| Randy E. Dobbs Director | Aug 19, 2026 | Option exercise | +4,191 | – | – | 146,444 |
| Randy E. Dobbs Director | Aug 19, 2026 | Option exercise | +16,763 | – | – | 142,253 |
| Timothy Smokoff Director | Aug 19, 2026 | Option exercise | +3,757 | – | – | 94,304 |
| Timothy Smokoff Director | Aug 19, 2026 | Returned to company | −3,757 | $8.94 | $33.59K | 90,547 |
| Timothy Smokoff Director | Aug 19, 2026 | Option exercise | +15,029 | – | – | 90,547 |
| Nitin Kaushal Director | Aug 19, 2026 | Option exercise | +18,786 | – | – | 161,361 |
| Sabrina Heltz Director | Aug 19, 2026 | Returned to company | −3,757 | $8.94 | $33.59K | 82,520 |
| Sabrina Heltz Director | Aug 19, 2026 | Option exercise | +3,757 | – | – | 86,277 |
| Sabrina Heltz Director | Aug 19, 2026 | Option exercise | +15,029 | – | – | 82,520 |
| William Frazier Chief Medical Officer, Director | Jun 25, 2026 | Option exercise | +10,000 | $1.81 | $18.10K | 83,214 |
| William Frazier Chief Medical Officer, Director | Jun 25, 2026 | Sale | −10,000 | $11.72 | $117.20K | 73,214 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −5,000 | $11.53 | $57.65K | 80,518 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −1,636 | $11.48 | $18.78K | 93,882 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −5,000 | $11.41 | $57.05K | 75,518 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −5,000 | $11.56 | $57.80K | 85,518 |
| Timothy Smokoff Director | Jun 24, 2026 | Sale | −3,364 | $11.50 | $38.69K | 90,518 |
| Michael Moore President | Mar 20, 2026 | Sale | −65,000 | $8.77 | $570.05K | 1,585,812 |
| Michael Moore President | Mar 19, 2026 | Sale | −40,232 | $9.21 | $370.54K | 1,650,812 |
| Michael Moore President | Mar 18, 2026 | Sale | −31,570 | $9.42 | $297.39K | 1,691,044 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Option exercise | +8,619 | – | – | 106,443 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Tax withholding | −2,355 | $7.48 | $17.62K | 104,088 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Option exercise | +2,873 | – | – | 106,961 |
| Jerome Cambre Vice President of Sales | Jan 29, 2026 | Returned to company | −2,873 | $7.48 | $21.49K | 104,088 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Option exercise | +10,774 | – | – | 49,431 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Tax withholding | −2,939 | $7.48 | $21.98K | 46,492 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Option exercise | +3,591 | – | – | 50,083 |
| Jeremy Trahan General Counsel | Jan 29, 2026 | Returned to company | −3,591 | $7.48 | $26.86K | 46,492 |
| Michael Moore President | Jan 29, 2026 | Tax withholding | −7,342 | $7.48 | $54.92K | 189,090 |
| Michael Moore President | Jan 29, 2026 | Option exercise | +26,842 | – | – | 196,432 |
| Michael Moore President | Jan 29, 2026 | Returned to company | −8,947 | $7.48 | $66.92K | 189,090 |
| Michael Moore President | Jan 29, 2026 | Option exercise | +8,947 | – | – | 198,037 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Returned to company | −3,265 | $7.48 | $24.42K | 105,638 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Option exercise | +9,794 | – | – | 108,317 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Tax withholding | −2,679 | $7.48 | $20.04K | 105,638 |
| Trae Fitzgerald Chief Financial Officer | Jan 29, 2026 | Option exercise | +3,265 | – | – | 108,903 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Option exercise | +26,842 | – | – | 401,677 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Tax withholding | −11,368 | $7.48 | $85.03K | 390,309 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Option exercise | +8,948 | – | – | 399,257 |
| William Todd Zehnder Chief Operating Officer, Director | Jan 29, 2026 | Returned to company | −8,948 | $7.48 | $66.93K | 390,309 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Tax withholding | −802 | $7.48 | $6.00K | 73,214 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Option exercise | +778 | – | – | 73,992 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Returned to company | −778 | $7.48 | $5.82K | 73,214 |
| William Frazier Chief Medical Officer, Director | Jan 29, 2026 | Option exercise | +2,334 | – | – | 74,016 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Option exercise | +39,795 | – | – | 364,377 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Tax withholding | −13,913 | $7.48 | $104.07K | 350,464 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Option exercise | +13,265 | – | – | 363,729 |
| Casey Hoyt Chief Executive Officer, Director | Jan 29, 2026 | Returned to company | −13,265 | $7.48 | $99.22K | 350,464 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Option exercise | +11,719 | – | – | 101,651 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Tax withholding | −3,827 | $7.49 | $28.66K | 97,824 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Returned to company | −2,930 | $7.49 | $21.95K | 97,824 |
| Jerome Cambre Vice President of Sales | Jan 21, 2026 | Option exercise | +2,930 | – | – | 100,754 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Option exercise | +12,400 | – | – | 336,982 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Tax withholding | −13,565 | $7.49 | $101.60K | 324,582 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Returned to company | −12,400 | $7.49 | $92.88K | 324,582 |
| Casey Hoyt Chief Executive Officer, Director | Jan 21, 2026 | Option exercise | +49,597 | – | – | 338,147 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Tax withholding | −4,246 | $7.49 | $31.80K | 98,523 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Option exercise | +13,317 | – | – | 102,769 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Returned to company | −3,329 | $7.49 | $24.93K | 98,523 |
| Trae Fitzgerald Chief Financial Officer | Jan 21, 2026 | Option exercise | +3,329 | – | – | 101,852 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Faster Llc Moore Officer | Mar 20, 2026 | 65,000 | $570.12K | Mar 20, 2026 | Merger/Acquisition |
| Faster Llc Moore Officer | Mar 19, 2026 | 40,232 | $370.42K | Mar 19, 2026 | Merger/Acquisition |
| Faster Llc Moore Officer | Mar 18, 2026 | 31,570 | $297.35K | Mar 18, 2026 | Merger/Acquisition |